Click here to view the Providence Health Plan Medical Policy Updates » September 2024 Providence…
Highmark Blue Cross Blue Shield November 2017 Medical Policy Updates
Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates »
November 2017 Medical Policy Updates:
- Spinal Muscular Atrophy Testing
- Chromosome Analysis for Blood, Bone Marrow, and Solid Tumor Cancers
- Leber Hereditary Optic Neuropathy (LHON) Genetic Testing
- BCR-ABL Negative Myeloproliferative Neoplasm Testing
- Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) Genetic Testing
- EGFR Testing for Non-Small Cell Lung Cancer TKI Response
- Peutz-Jeghers Syndrome Testing
- Dentatorubral-Pallidoluysian Atrophy Testing
- BRCA Analysis
- Bloom Syndrome Testing
- Gene Expression Profiling Tests for Prostate Cancer
- UroVysion FISH for Bladder Cancer
- Amyotrophic Lateral Sclerosis (ALS) Genetic Testing
- Cxbladder
- Von Hippel-Lindau Disease Testing
- Mitochondrial DNA Deletion Syndromes
- Familial Hypercholesterolemia Genetic Testing
- 4Kscore for Prostate Cancer Risk Assessment
- Myoclonic Epilepsy with Ragged Red Fibers (MERRF)
- BCR-ABL Testing for Chronic Myeloid Leukemia
- EndoPredict® for Breast Cancer Prognosis
- Duchenne & Becker Muscular Dystrophy Testing
- MGMT Testing for Malignant Glioma Alkylating Agent Response
- BRAF Testing for Melanoma Kinase Inhibitor Response
- OralCDx Brush Biopsy
- Mammaprint 70-Gene Breast Cancer Recurrence Assay
- Intracellular Micronutrient Testing Panel
- Genetic Testing by Multigene Panels
- UGT1A1 Targeted Mutation Analysis for Irinotecan Response
- Ataxia-Telangiectasia
- Rett Syndrome Testing
- GPS Cancer (NantHealth)
- Hematopoietic Stem Cell Transplantation for Amyloid light-chain (AL) Amyloidosis (Primary Systemic Amyloidosis)
- Desensitization Treatment for Heart and Renal Transplant
- MUTYH Associated Polyposis Testing
- Myeloma Prognostic Risk Signature (MyPRS)
- Tumor Markers
- Sept9 Methylation Analysis for Colorectal Cancer
- Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa (NARP)
- Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)
- Hereditary Cancer Syndrome Multigene Panels
- Huntington Disease Testing
- Whole Exome Sequencing
- Flow Cytometry
- WATS3D Biopsy (EndoCDx®)
- Aqueous Shunts and Stents for Glaucoma
- Expanded Carrier Screening Panels
- Familial Adenomatous Polyposis Testing
- Early Onset Familial Alzheimer Disease (EOFAD) Genetic Testing
- MTHFR Variant Analysis for Hyperhomocysteinemia
- CellSearch Circulating Tumor Cell Count for Breast Cancer Prognosis
- Hereditary (Germline) Testing After Tumor (Somatic) Testing
- Intraoperative Neurophysiologic Monitoring (Sensory-Evoked Potentials, Motor-Evoked Potentials, EEG Monitoring)
- Angelman Syndrome Testing
- APOE Variant Analysis for Alzheimer Disease
Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
